Qing Xiang

Title: Qing Xiang: Innovator in Macrolide Derivatives

Introduction

Qing Xiang is a notable inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of macrolide derivatives. His innovative work has implications for the treatment of various diseases through targeted inhibition of specific protein kinases.

Latest Patents

Qing Xiang holds a patent for macrolide derivatives, which includes a preparation method and its application. The patent describes a macrolide derivative represented by formula (I) and its use as an inhibitor of one or more protein kinases, including TRK, ALK, and ROS1. This advancement showcases his commitment to enhancing therapeutic options in modern medicine.

Career Highlights

Throughout his career, Qing Xiang has worked with prominent companies in the pharmaceutical industry. He has been associated with Zhejiang Hisun Pharmaceutical Co., Ltd. and Shanghai Aryl Pharmtech Co., Ltd. His experience in these organizations has allowed him to refine his expertise and contribute to groundbreaking research.

Collaborations

Qing Xiang has collaborated with talented individuals in his field, including Youxi Chen and Liang Gong. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Qing Xiang's contributions to the field of macrolide derivatives highlight his role as a significant inventor in the pharmaceutical industry. His work not only advances scientific knowledge but also has the potential to improve patient outcomes through innovative treatments.